Theragen Etex Co.,Ltd. (KOSDAQ:066700)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,840.00
-40.00 (-1.39%)
At close: Feb 13, 2026

Theragen Etex Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Revenue
268,132249,625216,470190,769166,567143,023
Other Revenue
---0-0--
268,132249,625216,470190,769166,567143,023
Revenue Growth (YoY)
9.55%15.32%13.47%14.53%16.46%3.58%
Cost of Revenue
129,898124,115116,344113,363105,39297,436
Gross Profit
138,234125,510100,12677,40661,17545,586
Selling, General & Admin
121,983105,92580,55559,73152,81042,461
Research & Development
4,3274,1284,0445,0386,5156,418
Amortization of Goodwill & Intangibles
59.784.588.5478.04216.99280.9
Other Operating Expenses
782.49764.24276.75405.44261.95314.47
Operating Expenses
130,689113,86488,65365,55368,60253,053
Operating Income
7,54511,64611,47311,853-7,427-7,467
Interest Expense
-2,545-2,676-2,418-1,343-1,691-2,145
Interest & Investment Income
966.67776.69799.02340.94327.69359.15
Earnings From Equity Investments
2,6235,695----
Currency Exchange Gain (Loss)
292.65126.412.63.7997.9-58.87
Other Non Operating Income (Expenses)
-1,956-2,486396.13-369.03-2,1361,380
EBT Excluding Unusual Items
6,92613,08210,25310,486-10,829-7,931
Gain (Loss) on Sale of Investments
-56,047-56,03622,164-60.8512.93-44.64
Gain (Loss) on Sale of Assets
9.53150.68-46.624,231-219.2-66.21
Asset Writedown
-26.22-26.22-62.69-800.7-1,477-297.74
Other Unusual Items
-366.51-329.08439.82--163.19-
Pretax Income
-49,504-43,15932,74713,855-12,676-8,340
Income Tax Expense
-5,233-3,0183,0691,428-1,291739.5
Earnings From Continuing Operations
-44,272-40,14129,67912,428-11,385-9,079
Earnings From Discontinued Operations
-860.46-1,287-1,477--
Net Income to Company
-44,272-39,28128,39210,951-11,385-9,079
Minority Interest in Earnings
-2,177-1,704-2,180-1,389-469.31111.76
Net Income
-46,449-40,98526,2119,561-11,854-8,968
Net Income to Common
-46,449-40,98526,2119,561-11,854-8,968
Net Income Growth
--174.14%---
Shares Outstanding (Basic)
373232323231
Shares Outstanding (Diluted)
373232323231
Shares Change (YoY)
27.41%--0.04%1.88%-3.02%
EPS (Basic)
-1244.95-1280.56818.97298.74-370.52-285.57
EPS (Diluted)
-1244.95-1280.56818.97297.86-371.00-285.57
EPS Growth
--174.95%---
Free Cash Flow
1,764-9,6047,3285,4011,25710,214
Free Cash Flow Per Share
47.28-300.06228.96168.7439.30325.27
Gross Margin
51.55%50.28%46.25%40.58%36.73%31.87%
Operating Margin
2.81%4.67%5.30%6.21%-4.46%-5.22%
Profit Margin
-17.32%-16.42%12.11%5.01%-7.12%-6.27%
Free Cash Flow Margin
0.66%-3.85%3.38%2.83%0.76%7.14%
EBITDA
14,00117,74317,31716,945-2,387-2,812
EBITDA Margin
5.22%7.11%8.00%8.88%-1.43%-1.97%
D&A For EBITDA
6,4566,0965,8445,0925,0414,655
EBIT
7,54511,64611,47311,853-7,427-7,467
EBIT Margin
2.81%4.67%5.30%6.21%-4.46%-5.22%
Effective Tax Rate
--9.37%10.30%--
Advertising Expenses
-471.65430.63430.06194.09258.37
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.